Efficacy
tumor
TUMOR
In the ITT population, CRR was 56.5% (90% CI, 37.5-74.2; CRR in the ITT population.

Abbreviations: CRR, composite response rate; CTC, circulating tumor cell; ITT, intent-to-treat; N/A, not applicable; NIRA + AAP, niraparib 200 mg, abiraterone acetate 1000 mg, and prednisone 10 mg; ORR, objective response rate; PSA50, prostate-specific antigen decline ≥50%.